SEC Form 4 · accession 0001213900-18-005284
NEXEON MEDSYSTEMS INC · NXNN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Blischak
Officer — President / CCO
Period of report
Aug 31, 2017
Accepted (ET)
May 1, 2018 · 1:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001416172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Aug 31, 2017 | A | 6,009 | $0.625 | A | 6,009 | D | |
| COMMON STOCKF1 | Sep 15, 2017 | A | 6,009 | $0.625 | A | 12,018 | D | |
| COMMON STOCKF1 | Sep 30, 2017 | A | 5,934 | $0.625 | A | 17,952 | D | |
| COMMON STOCKF1 | Oct 15, 2017 | A | 5,934 | $0.625 | A | 23,886 | D | |
| COMMON STOCKF1 | Oct 31, 2017 | A | 5,934 | $0.625 | A | 29,820 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OPTIONSF2 | $0.76 | Feb 28, 2018 | A | 57,000 | A | Feb 28, 2018 | Feb 28, 2026 | COMMON STOCK | 57,000 | 57,000 | D |
Explanation of responses
- F1On August 21, 2017, the Company offered to current employees the opportunity to purchase shares of the Company's restricted Common Stock for a discount through payroll deductions. Between August 31, 2017 and October 31, 2017, the Reporting Person acquired 29,820 shares of the Company's restricted common stock through a subscription of the shares as compensation for service as President and Chief Commercial Officer of the Company. These shares were valued at $18,638 ($0.625 per share).
- F2On February 28, 2018, and pursuant to the Company's 2016 Ominbus Incentive Plan, the Company granted to the Reporting Person an option (the "Option") to purchase 57,000 shares of the Company's restricted common stock, at a price of $0.76 per share, as compensation for service as President and Chief Commercial Officer of the Company. The term of the Option shall be for a period of eight (8) years from the date of issue. The fair value of the Option was determined to be $12,855 using the Black-Sholes Option Pricing Model. The Option was immediately exercisable at date of issue.